https://m2.mtmt.hu/eng2024-03-28 15:37falsetrue4039339333010110DESCpublishedYearfalseDESCissuefalseJournalArticle34612989VALIDATEDtrue0false2024-02-17T21:33:17.268+00002024-02-17T21:31:47.017+00002024-02-17T21:31:45.959+0000true521SzuperAdmin
/api/admin/521
Admintrue2024-02-17T21:31:45.786+00002024-02-17T21:31:45.786+00002024-02-17T21:31:46.178+0000true521SzuperAdmin
/api/admin/521
Admintruefalsefalsetrue2424
/api/publicationtype/24
PublicationType1true24JournalArticletrue10000059Articletrue2424
/api/publicationtype/24
PublicationType1true24JournalArticle
/api/subtype/10000059
SzakcikkSubType101true10000059true1
/api/category/1
Categorytrue1Song, Ji-EunMulti-MicroRNA Analysis Can Improve the Diagnostic Performance of Mammography in Determining Breast Cancer Risktruetrue
/api/journal/10006504
REVIEWEDtruefalse10006504false10006504true1075-122X1524-4741JournalFOREIGN202391170479117047132023The objective of this study was to determine whether multi-microRNA analysis using a combination of four microRNA biomarkers (miR-1246, 202, 21, and 219B) could improve the diagnostic performance of mammography in determining breast cancer risk by age group (under 50 vs. over 50) and distinguish breast cancer from benign breast diseases and other cancers (thyroid, colon, stomach, lung, liver, and cervix cancers). To verify breast cancer classification performance of the four miRNA biomarkers and whether the model providing breast cancer risk score could distinguish between benign breast disease and other cancers, the model was verified using nonlinear support vector machine (SVM) and generalized linear model (GLM) and age and four miRNA qRT-PCR analysis values (dCt) were input to these models. Breast cancer risk scores for each Breast Imaging-Reporting and Data System (BI-RADS) category in multi-microRNA analysis were analyzed to examine the correlation between breast cancer risk scores and mammography categories. We generated two models using two classification algorithms, SVM and GLM, with a combination of four miRNA biomarkers showing high performance and sensitivities of 84.5% and 82.1%, a specificity of 85%, and areas under the curve (AUCs) of 0.967 and 0.965, respectively, which showed consistent performance across all stages of breast cancer and patient ages. The results of this study showed that this multi-microRNA analysis using the four miRNA biomarkers was effective in classifying breast cancer in patients under the age of 50, which is challenging to accurately diagnose. In addition, breast cancer and benign breast diseases can be classified, showing the possibility of helping with diagnosis by mammography. Verification of the performance of the four miRNA biomarkers confirmed that multi-microRNA analysis could be used as a new breast cancer screening aid to improve the accuracy of mammography. However, many factors must be considered for clinical use. Further validation with an appropriate screening population in large clinical trials is required. This trial is registered with (KNUCH 2022-04-036).2024truetruetruefalsefalseNONE2024-02-17false00000000000011Q2falsefalsefalsefalse13060trueLanguage10002
/api/language/10002
AngolEnglishtrue2truePersonAuthorship114688607
/api/authorship/114688607
10.16666667truefalsefalseSongJi-EuntruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship114688608
/api/authorship/114688608
20.16666667falsefalsefalseJangJi YoungtruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship114688609
/api/authorship/114688609
30.16666667falsefalsefalseKangKyung NamtruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship114688610
/api/authorship/114688610
40.16666667falsefalsefalseJungJi SootruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship114688611
/api/authorship/114688611
50.16666667falsefalsefalseKimChul WootruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship114688612
/api/authorship/114688612
60.16666667falsetruetrueKimAh SoltruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePublicationIdentifier25568018
/api/publicationidentifier/25568018
10.1155/2023/9117047https://doi.org/10.1155/2023/9117047falsetruePublicationIdentifier25568017
/api/publicationidentifier/25568017
IDENTICAL001137301300001https://www.webofscience.com/wos/woscc/full-record/001137301300001falsetrueClassification12215
/api/classification/12215
truetrueSjrRating11419309
/api/sjrrating/11419309
2530.49journalRatingType10002
/api/ratingtype/10002
sjrtruetrueClassificationExternal2746
/api/classificationexternal/2746
true2746trueQ2FROM_LAST_YEARtruetrue
/api/publication/34612989
<div class="JournalArticle Publication short-list"> <div class="authors"> <span class="author-name" > Song, Ji-Eun </span> <span class="author-type"> </span> ; <span class="author-name" > Jang, Ji Young </span> <span class="author-type"> </span> ; <span class="author-name" > Kang, Kyung Nam </span> <span class="author-type"> </span> ; <span class="author-name" > Jung, Ji Soo </span> <span class="author-type"> </span> ; <span class="author-name" > Kim, Chul Woo </span> <span class="author-type"> </span> ; <span class="author-name" > Kim, Ah Sol ✉ </span> <span class="author-type"> </span> </div ><div class="title"><a href="/gui2/?mode=browse¶ms=publication;34612989" mtid="34612989" target="_blank">Multi-MicroRNA Analysis Can Improve the Diagnostic Performance of Mammography in Determining Breast Cancer Risk</a></div> <div class="pub-info"> <span class="journal-title">BREAST JOURNAL</span> <span class="journal-volume">2023</span> <span class="page"> Paper: 9117047 , 13 p. </span> <span class="year">(2023)</span> </div> <div class="pub-end"><div class="identifier-list"> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:black" title="10.1155/2023/9117047" target="_blank" href="https://doi.org/10.1155/2023/9117047"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="001137301300001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001137301300001"> WoS </a> </span> </span> </div> <div class="short-pub-prop-list"> <span class="short-pub-mtid"> Publication:34612989 </span> <span class="status-holder"><span class="status-data status-VALIDATED"> Validated </span></span> <span class="pub-core"> Citing </span> <span class="pub-type">Journal Article (Article ) </span> <!-- && !record.category.scientific --> <span class="pub-category">Scientific</span> </div> </div> </div><div class="JournalArticle Publication long-list">
<div class="authors">
<img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png">
<div class="autype autype0"> <span class="author-name" >Song Ji-Eun
</span>
;
<span class="author-name" >Jang Ji Young
</span>
;
<span class="author-name" >Kang Kyung Nam
</span>
;
<span class="author-name" >Jung Ji Soo
</span>
;
<span class="author-name" >Kim Chul Woo
</span>
;
<span class="author-name" >Kim Ah Sol ✉
</span>
</div>
</div>
<div class="title"><a href="/gui2/?mode=browse¶ms=publication;34612989" target="_blank">Multi-MicroRNA Analysis Can Improve the Diagnostic Performance of Mammography in Determining Breast Cancer Risk</a></div> <div> <span class="journal-title">BREAST JOURNAL</span>
<span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/1075-122X">1075-122X</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1524-4741">1524-4741</a>)</span>:
<span class="journal-volume">2023</span>
<span class="page">
Paper 9117047.
13 p.
</span> <span class="year">(2023)</span>
</div>
<div class="pub-footer">
<span class="language" xmlns="http://www.w3.org/1999/html">Language:
English
| </span>
<span class="identifiers">
<span class="id identifier oa_none" title="none">
<a style="color:black" title="10.1155/2023/9117047" target="_blank" href="https://doi.org/10.1155/2023/9117047">
DOI
</a>
</span>
<span class="id identifier oa_none" title="none">
<a style="color:blue" title="001137301300001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001137301300001">
WoS
</a>
</span>
</span>
<div class="publication-citation">
<a target="_blank" href="/api/publication?cond=citations.related;eq;34612989&sort=publishedYear,desc&sort=title">
Number of cited publications: 1
</a>
</div>
<div class="mtid"><span class="long-pub-mtid">Publication: 34612989</span>
| <span class="status-data status-VALIDATED"> Validated
</span>
Citing
| <span class="type-subtype">Journal Article
( Article
)
</span>
| <span class="pub-category">Scientific</span>
| <span class="publication-sourceOfData">WoS-XML</span>
</div>
<div class="lastModified">Last Modified: 2024.02.17. 22:31 Admin Szuper (admin)
</div>
</div></div>JournalArticle34300441VALIDATEDtrue0false2023-12-14T13:22:59.148+00002023-12-14T13:04:02.203+00002023-11-11T15:51:27.340+0000true521SzuperAdmin
/api/admin/521
Admintrue2023-11-11T15:51:27.164+00002023-11-11T15:51:27.164+00002023-11-11T15:51:27.557+0000true521SzuperAdmin
/api/admin/521
Admintruefalsefalsetrue2424
/api/publicationtype/24
PublicationType1true24JournalArticletrue10000059Articletrue2424
/api/publicationtype/24
PublicationType1true24JournalArticle
/api/subtype/10000059
SzakcikkSubType101true10000059true1
/api/category/1
Categorytrue1Elnaghi, Khaled Abd Elaziz AhmedHormonal-Receptors-Positive and HER2-Negative Patients with Metastatic Breast Cancer Treated with First-Line Palbociclib and Hormonal Therapy: Impact of First-Cycle Neutropenia and Dose Reduction on Therapeutic Outcometruetrue
/api/journal/10006504
REVIEWEDtruefalse10006504false10006504true1075-122X1524-4741JournalFOREIGN202389949548994954102023Background. CDK 4/6 inhibitors with hormonal therapy are the standard first-line therapy in metastatic hormonal receptors (HR)-positive and HER2-negative breast cancer. This study aims to assess the impact of neutropenia with 1st cycle, dose reduction, HER2-low status, and other clinicopathological factors on survival outcomes with the first-line palbociclib and hormonal therapy. Patients and Methods. In this retrospective study, we recruited patients with metastatic HR-positive and HER2-negative breast cancer. Neutropenia with 1st cycle, palbociclib dose reduction in addition to different clinicopathological and survival data were checked in patients' medical records. Survival outcomes were compared according to the abovementioned factors. Results. We recruited 150 patients who received first-line palbociclib with hormonal therapy. 86% of patients developed 1st cycle neutropenia which was more common in patients with high Ki67. Dose reduction was recorded in 46.7% of patients and it was more common in patients with higher Allred scores (scores 7-8). The median progression-free survival (PFS) of the study group was 22 months. No significant difference was observed in PFS according to the 1st cycle of neutropenia or grade of neutropenia. Similarly, no difference in PFS according to palbociclib dose reduction and HER2 low status was observed. Only the Allred score and having a single site of metastasis had an independent significant relation with PFS. The median overall survival (OS) of the study group was 39 months. No significant difference was observed in OS according to the 1st cycle neutropenia, grade of neutropenia, palbociclib dose reduction, and HER2-low status. Only the Allred score and having a single site of metastasis had an independent significant relation with OS. In addition, no difference was observed in PFS and OS according to ECOG PS (2 vs. 0-1) or menopausal status. Conclusion. No significant impact of the 1st cycle neutropenia, dose reduction, having ECOG PS2, menopausal status, or HER2 low status on survival outcome was observed. Survival outcome was significantly better in patients with single metastatic sites and higher ER-Allred scores.2023truetruetruefalsefalseNONE2023-12-14false00000000000011Q2falsefalsefalsefalse26060trueLanguage10002
/api/language/10002
AngolEnglishtrue2truePersonAuthorship111607214
/api/authorship/111607214
10.16666667truefalsefalseElnaghiKhaled Abd Elaziz AhmedtruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship111607215
/api/authorship/111607215
20.16666667falsefalsetrueAlghanmiHosam AlitruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship111607216
/api/authorship/111607216
30.16666667falsefalsefalseElsamanyShereef AhmedtruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship111607217
/api/authorship/111607217
40.16666667falsefalsefalseAlmarzokiFathiatruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship111607218
/api/authorship/111607218
50.16666667falsefalsefalseElsaftyMohamedtruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship111607219
/api/authorship/111607219
60.16666667falsetruefalseJaffalMohammadtruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePublicationIdentifier24789747
/api/publicationidentifier/24789747
10.1155/2023/8994954https://doi.org/10.1155/2023/8994954falsetruePublicationIdentifier24789746
/api/publicationidentifier/24789746
IDENTICAL001057771400001https://www.webofscience.com/wos/woscc/full-record/001057771400001falsetruePublicationIdentifier25107253
/api/publicationidentifier/25107253
85150311369http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85150311369truetrueClassification12215
/api/classification/12215
truetrueSjrRating11419309
/api/sjrrating/11419309
2530.49journalRatingType10002
/api/ratingtype/10002
sjrtruetrueClassificationExternal2746
/api/classificationexternal/2746
true2746trueQ2FROM_LAST_YEARtruetrue
/api/publication/34300441
<div class="JournalArticle Publication short-list"> <div class="authors"> <span class="author-name" > Elnaghi, Khaled Abd Elaziz Ahmed </span> <span class="author-type"> </span> ; <span class="author-name" > Alghanmi, Hosam Ali ✉ </span> <span class="author-type"> </span> ; <span class="author-name" > Elsamany, Shereef Ahmed </span> <span class="author-type"> </span> ; <span class="author-name" > Almarzoki, Fathia </span> <span class="author-type"> </span> ; <span class="author-name" > Elsafty, Mohamed </span> <span class="author-type"> </span> ; <span class="author-name" > Jaffal, Mohammad </span> <span class="author-type"> </span> </div ><div class="title"><a href="/gui2/?mode=browse¶ms=publication;34300441" mtid="34300441" target="_blank">Hormonal-Receptors-Positive and HER2-Negative Patients with Metastatic Breast Cancer Treated with First-Line Palbociclib and Hormonal Therapy: Impact of First-Cycle Neutropenia and Dose Reduction on Therapeutic Outcome</a></div> <div class="pub-info"> <span class="journal-title">BREAST JOURNAL</span> <span class="journal-volume">2023</span> <span class="page"> Paper: 8994954 , 10 p. </span> <span class="year">(2023)</span> </div> <div class="pub-end"><div class="identifier-list"> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:black" title="10.1155/2023/8994954" target="_blank" href="https://doi.org/10.1155/2023/8994954"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="001057771400001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001057771400001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:black" title="85150311369" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85150311369"> Scopus </a> </span> </span> </div> <div class="short-pub-prop-list"> <span class="short-pub-mtid"> Publication:34300441 </span> <span class="status-holder"><span class="status-data status-VALIDATED"> Validated </span></span> <span class="pub-core"> Citing </span> <span class="pub-type">Journal Article (Article ) </span> <!-- && !record.category.scientific --> <span class="pub-category">Scientific</span> </div> </div> </div><div class="JournalArticle Publication long-list">
<div class="authors">
<img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png">
<div class="autype autype0"> <span class="author-name" >Elnaghi Khaled Abd Elaziz Ahmed
</span>
;
<span class="author-name" >Alghanmi Hosam Ali ✉
</span>
;
<span class="author-name" >Elsamany Shereef Ahmed
</span>
;
<span class="author-name" >Almarzoki Fathia
</span>
;
<span class="author-name" >Elsafty Mohamed
</span>
;
<span class="author-name" >Jaffal Mohammad
</span>
</div>
</div>
<div class="title"><a href="/gui2/?mode=browse¶ms=publication;34300441" target="_blank">Hormonal-Receptors-Positive and HER2-Negative Patients with Metastatic Breast Cancer Treated with First-Line Palbociclib and Hormonal Therapy: Impact of First-Cycle Neutropenia and Dose Reduction on Therapeutic Outcome</a></div> <div> <span class="journal-title">BREAST JOURNAL</span>
<span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/1075-122X">1075-122X</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1524-4741">1524-4741</a>)</span>:
<span class="journal-volume">2023</span>
<span class="page">
Paper 8994954.
10 p.
</span> <span class="year">(2023)</span>
</div>
<div class="pub-footer">
<span class="language" xmlns="http://www.w3.org/1999/html">Language:
English
| </span>
<span class="identifiers">
<span class="id identifier oa_none" title="none">
<a style="color:black" title="10.1155/2023/8994954" target="_blank" href="https://doi.org/10.1155/2023/8994954">
DOI
</a>
</span>
<span class="id identifier oa_none" title="none">
<a style="color:blue" title="001057771400001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001057771400001">
WoS
</a>
</span>
<span class="id identifier oa_none" title="none">
<a style="color:black" title="85150311369" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85150311369">
Scopus
</a>
</span>
</span>
<div class="publication-citation">
<a target="_blank" href="/api/publication?cond=citations.related;eq;34300441&sort=publishedYear,desc&sort=title">
Number of cited publications: 1
</a>
</div>
<div class="mtid"><span class="long-pub-mtid">Publication: 34300441</span>
| <span class="status-data status-VALIDATED"> Validated
</span>
Citing
| <span class="type-subtype">Journal Article
( Article
)
</span>
| <span class="pub-category">Scientific</span>
| <span class="publication-sourceOfData">WoS-XML</span>
</div>
<div class="lastModified">Last Modified: 2023.12.14. 14:04 Tamásné Gere (SE_KK_Admin5_GT, admin)
</div>
</div></div>JournalArticle34039665VALIDATEDtrueDepartment of Clinical Therapeutics, Alexandra Hospital, Medical School, Athens, Greece
Clinical Immunology-Rheumatology Unit, 2nd Department of Medicine and Laboratory, National and Kapodistrian University, Athens School of Medicine, Hippokration General Hospital, Athens, Greece
Oncology Section, Second Department of Internal Medicine, Hippokration Hospital, Athens, Greece
Export Date: 29 June 2023
CODEN: BRJOF
Correspondence Address: Zagouri, F.; Department of Clinical Therapeutics, Greece; email: florazagouri@yahoo.co.uk0false2024-02-19T10:19:32.384+00002023-06-29T11:12:04.895+00002023-06-29T11:07:37.992+0000true10081340PirmannTamás
/api/admin/10081340
Admintrue2024-02-19T09:42:24.397+00002023-11-06T13:29:08.380+0000true521SzuperAdmin
/api/admin/521
Admintruefalsefalsetrue2424
/api/publicationtype/24
PublicationType1true24JournalArticletrue1134514Survey papertrue2424
/api/publicationtype/24
PublicationType1true24JournalArticle
/api/subtype/1134514
Összefoglaló cikkSubType102true1134514true1
/api/category/1
Categorytrue1Skafida, E.Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant Settingtruetrue
/api/journal/10006504
REVIEWEDtruefalse10006504false10006504true1075-122X1524-4741JournalFOREIGN20233614296361429620232023truetruetruefalsefalseNONE2024-02-19false00000000000077Q2falsefalsefalsefalse2023-09-27T11:12:04.637+0000818090trueLanguage10002
/api/language/10002
AngolEnglishtrue2truePersonAuthorship109114304
/api/authorship/109114304
10.11111111truefalsefalseSkafidaE.truefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship109114305
/api/authorship/109114305
20.11111111falsefalsefalseAndrikopoulouA.truefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship109114306
/api/authorship/109114306
30.11111111falsefalsefalseTerposE.truefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship109114307
/api/authorship/109114307
40.11111111falsefalsefalseMarkellosC.truefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship109114308
/api/authorship/109114308
50.11111111falsefalsefalseMoustafaS.truefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship109114309
/api/authorship/109114309
60.11111111falsefalsefalsePectasidesD.truefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship109114310
/api/authorship/109114310
70.11111111falsefalsefalseDimopoulosM.-A.truefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship109114311
/api/authorship/109114311
80.11111111falsefalsetrueZagouriF.truefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship109114312
/api/authorship/109114312
90.11111111falsetruefalseVassilopoulosD.truefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePublicationIdentifier24098076
/api/publicationidentifier/24098076
IDENTICAL10.1155/2023/3614296https://doi.org/10.1155/2023/3614296falsetruePublicationIdentifier24098077
/api/publicationidentifier/24098077
IDENTICAL001004332100001https://www.webofscience.com/wos/woscc/full-record/001004332100001falsetruePublicationIdentifier24098075
/api/publicationidentifier/24098075
IDENTICAL85161865005http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85161865005falsetruePublicationIdentifier24491024
/api/publicationidentifier/24491024
IDENTICAL37293258http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=37293258&dopt=AbstractfalsetrueSjrRating11419309
/api/sjrrating/11419309
2530.49journalRatingType10002
/api/ratingtype/10002
sjrtruetrueClassificationExternal2746
/api/classificationexternal/2746
true2746trueQ2FROM_LAST_YEARtruetrue
/api/publication/34039665
<div class="JournalArticle Publication short-list"> <div class="authors"> <span class="author-name" > Skafida, E. </span> <span class="author-type"> </span> ; <span class="author-name" > Andrikopoulou, A. </span> <span class="author-type"> </span> ; <span class="author-name" > Terpos, E. </span> <span class="author-type"> </span> ; <span class="author-name" > Markellos, C. </span> <span class="author-type"> </span> ; <span class="author-name" > Moustafa, S. </span> <span class="author-type"> </span> ; <span class="author-name" > Pectasides, D. </span> <span class="author-type"> </span> ; <span class="author-name" > Dimopoulos, M.-A. </span> <span class="author-type"> </span> ; <span class="author-name" > Zagouri, F. ✉ </span> <span class="author-type"> </span> ; <span class="author-name" > Vassilopoulos, D. </span> <span class="author-type"> </span> </div ><div class="title"><a href="/gui2/?mode=browse¶ms=publication;34039665" mtid="34039665" target="_blank">Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant Setting</a></div> <div class="pub-info"> <span class="journal-title">BREAST JOURNAL</span> <span class="journal-volume">2023</span> <span class="page"> Paper: 3614296 </span> <span class="year">(2023)</span> </div> <div class="pub-end"><div class="identifier-list"> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.1155/2023/3614296" target="_blank" href="https://doi.org/10.1155/2023/3614296"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="001004332100001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001004332100001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85161865005" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85161865005"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="37293258" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=37293258&dopt=Abstract"> PubMed </a> </span> </span> </div> <div class="short-pub-prop-list"> <span class="short-pub-mtid"> Publication:34039665 </span> <span class="status-holder"><span class="status-data status-VALIDATED"> Validated </span></span> <span class="pub-core"> Citing </span> <span class="pub-type">Journal Article (Survey paper ) </span> <!-- && !record.category.scientific --> <span class="pub-category">Scientific</span> </div> </div> </div><div class="JournalArticle Publication long-list">
<div class="authors">
<img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png">
<div class="autype autype0"> <span class="author-name" >Skafida E.
</span>
;
<span class="author-name" >Andrikopoulou A.
</span>
;
<span class="author-name" >Terpos E.
</span>
;
<span class="author-name" >Markellos C.
</span>
;
<span class="author-name" >Moustafa S.
</span>
;
<span class="author-name" >Pectasides D.
</span>
;
<span class="author-name" >Dimopoulos M.-A.
</span>
;
<span class="author-name" >Zagouri F. ✉
</span>
;
<span class="author-name" >Vassilopoulos D.
</span>
</div>
</div>
<div class="title"><a href="/gui2/?mode=browse¶ms=publication;34039665" target="_blank">Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant Setting</a></div> <div> <span class="journal-title">BREAST JOURNAL</span>
<span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/1075-122X">1075-122X</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1524-4741">1524-4741</a>)</span>:
<span class="journal-volume">2023</span>
<span class="page">
Paper 3614296.
</span> <span class="year">(2023)</span>
</div>
<div class="pub-footer">
<span class="language" xmlns="http://www.w3.org/1999/html">Language:
English
| </span>
<span class="identifiers">
<span class="id identifier oa_none" title="none">
<a style="color:blue" title="10.1155/2023/3614296" target="_blank" href="https://doi.org/10.1155/2023/3614296">
DOI
</a>
</span>
<span class="id identifier oa_none" title="none">
<a style="color:blue" title="001004332100001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001004332100001">
WoS
</a>
</span>
<span class="id identifier oa_none" title="none">
<a style="color:blue" title="85161865005" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85161865005">
Scopus
</a>
</span>
<span class="id identifier oa_none" title="none">
<a style="color:blue" title="37293258" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=37293258&dopt=Abstract">
PubMed
</a>
</span>
</span>
<div class="publication-citation">
<a target="_blank" href="/api/publication?cond=citations.related;eq;34039665&sort=publishedYear,desc&sort=title">
Number of cited publications: 7
</a>
</div>
<div class="mtid"><span class="long-pub-mtid">Publication: 34039665</span>
| <span class="status-data status-VALIDATED"> Validated
</span>
Citing
| <span class="type-subtype">Journal Article
( Survey paper
)
</span>
| <span class="pub-category">Scientific</span>
| <span class="publication-sourceOfData">Scopus</span>
</div>
<div class="lastModified">Last Modified: 2023.06.29. 13:12 Tamás Pirmann (OOI addmin5, admin)
</div>
<pre class="comment" style="margin-top: 0; margin-bottom: 0;"><u>Comments</u>: Department of Clinical Therapeutics, Alexandra Hospital, Medical School, Athens, Greece
Clinical Immunology-Rheumatology Unit, 2nd Department of Medicine and Laboratory, National and Kapodistrian University, Athens School of Medicine, Hippokration General Hospital, Athens, Greece
Oncology Section, Second Department of Internal Medicine, Hippokrati...</pre>
</div></div>JournalArticle33911892VALIDATEDtrueCited By :1
Export Date: 9 October 2023
CODEN: BRJOF
Correspondence Address: Zhang, L.; Third Affiliated Hospital of Zhengzhou University, China; email: 540185181@qq.com
Chemicals/CAS: pentetic acid, 14047-41-7, 67-43-6; proton, 12408-02-5, 12586-59-3; Ki-67 Antigen
Tradenames: Signa Pioneer, GE Healthcare, United States
Manufacturers: GE Healthcare; GE Healthcare, United States0false2023-10-09T12:38:05.371+00002023-05-29T22:37:01.186+00002023-05-29T22:36:59.317+0000true521SzuperAdmin
/api/admin/521
Admintrue2023-10-09T12:36:36.570+00002023-05-29T22:36:59.594+0000true521SzuperAdmin
/api/admin/521
Admintruefalsefalsetrue2424
/api/publicationtype/24
PublicationType1true24JournalArticletrue10000059Articletrue2424
/api/publicationtype/24
PublicationType1true24JournalArticle
/api/subtype/10000059
SzakcikkSubType101true10000059true1
/api/category/1
Categorytrue1Zhang, LiyingPredicting of Ki-67 Expression Level Using Diffusion-Weighted and Synthetic Magnetic Resonance Imaging in Invasive Ductal Breast Cancertruetrue
/api/journal/10006504
REVIEWEDtruefalse10006504false10006504true1075-122X1524-4741JournalFOREIGN20236746326674632682023Objectives. To investigate the association between quantitative parameters generated using synthetic magnetic resonance imaging (SyMRI) and diffusion-weighted imaging (DWI) and Ki-67 expression level in patients with invasive ductal breast cancer (IDC). Method. We retrospectively reviewed the records of patients with IDC who underwent SyMRI and DWI before treatment. Precontrast and postcontrast relaxation times (T1, longitudinal; T2, transverse), proton density (PD) parameters, and apparent diffusion coefficient (ADC) values were measured in breast lesions. Univariate and multivariate regression analyses were performed to screen for statistically significant variables to differentiate the high (=30%) and low (<30%) Ki-67 expression groups. Their performance was evaluated by receiver operating characteristic (ROC) curve analysis. Results. We analyzed 97 patients. Multivariate regression analysis revealed that the high Ki-67 expression group (n = 57) had significantly higher parameters generated using SyMRI (pre-T1, p = 0.001) and lower ADC values (p = 0.036) compared with the low Ki-67 expression group (n = 40). Pre-T1 showed the best diagnostic performance for predicting the Ki-67 expression level in patients with invasive ductal breast cancer (areas under the ROC curve (AUC), 0.711; 95% confidence interval (CI), 0.609-0.813). Conclusions. Pre-T1 could be used to predict the pretreatment Ki-67 expression level in invasive ductal breast cancer.2023truetruetruefalsefalseNONE2023-10-09false00000000000022Q2falsefalsefalsefalse1038050trueLanguage10002
/api/language/10002
AngolEnglishtrue2truePersonAuthorship108286079
/api/authorship/108286079
10.2truefalsetrueZhangLiyingtruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship108286080
/api/authorship/108286080
20.2falsefalsefalseHaoJisentruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship108286081
/api/authorship/108286081
30.2falsefalsefalseGuoJiatruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship108286082
/api/authorship/108286082
40.2falsefalsefalseZhaoXintruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship108286083
/api/authorship/108286083
50.2falsetruefalseYinXingtruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePublicationIdentifier23785195
/api/publicationidentifier/23785195
IDENTICAL10.1155/2023/6746326https://doi.org/10.1155/2023/6746326falsetruePublicationIdentifier23785194
/api/publicationidentifier/23785194
IDENTICAL000971801800001https://www.webofscience.com/wos/woscc/full-record/000971801800001falsetruePublicationIdentifier24483209
/api/publicationidentifier/24483209
IDENTICAL85152633565http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85152633565falsetrueClassification12215
/api/classification/12215
truetrueSjrRating11419309
/api/sjrrating/11419309
2530.49journalRatingType10002
/api/ratingtype/10002
sjrtruetrueClassificationExternal2746
/api/classificationexternal/2746
true2746trueQ2FROM_LAST_YEARtruetrue
/api/publication/33911892
<div class="JournalArticle Publication short-list"> <div class="authors"> <span class="author-name" > Zhang, Liying ✉ </span> <span class="author-type"> </span> ; <span class="author-name" > Hao, Jisen </span> <span class="author-type"> </span> ; <span class="author-name" > Guo, Jia </span> <span class="author-type"> </span> ; <span class="author-name" > Zhao, Xin </span> <span class="author-type"> </span> ; <span class="author-name" > Yin, Xing </span> <span class="author-type"> </span> </div ><div class="title"><a href="/gui2/?mode=browse¶ms=publication;33911892" mtid="33911892" target="_blank">Predicting of Ki-67 Expression Level Using Diffusion-Weighted and Synthetic Magnetic Resonance Imaging in Invasive Ductal Breast Cancer</a></div> <div class="pub-info"> <span class="journal-title">BREAST JOURNAL</span> <span class="journal-volume">2023</span> <span class="page"> Paper: 6746326 , 8 p. </span> <span class="year">(2023)</span> </div> <div class="pub-end"><div class="identifier-list"> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.1155/2023/6746326" target="_blank" href="https://doi.org/10.1155/2023/6746326"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="000971801800001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/000971801800001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85152633565" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85152633565"> Scopus </a> </span> </span> </div> <div class="short-pub-prop-list"> <span class="short-pub-mtid"> Publication:33911892 </span> <span class="status-holder"><span class="status-data status-VALIDATED"> Validated </span></span> <span class="pub-core"> Citing </span> <span class="pub-type">Journal Article (Article ) </span> <!-- && !record.category.scientific --> <span class="pub-category">Scientific</span> </div> </div> </div><div class="JournalArticle Publication long-list">
<div class="authors">
<img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png">
<div class="autype autype0"> <span class="author-name" >Zhang Liying ✉
</span>
;
<span class="author-name" >Hao Jisen
</span>
;
<span class="author-name" >Guo Jia
</span>
;
<span class="author-name" >Zhao Xin
</span>
;
<span class="author-name" >Yin Xing
</span>
</div>
</div>
<div class="title"><a href="/gui2/?mode=browse¶ms=publication;33911892" target="_blank">Predicting of Ki-67 Expression Level Using Diffusion-Weighted and Synthetic Magnetic Resonance Imaging in Invasive Ductal Breast Cancer</a></div> <div> <span class="journal-title">BREAST JOURNAL</span>
<span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/1075-122X">1075-122X</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1524-4741">1524-4741</a>)</span>:
<span class="journal-volume">2023</span>
<span class="page">
Paper 6746326.
8 p.
</span> <span class="year">(2023)</span>
</div>
<div class="pub-footer">
<span class="language" xmlns="http://www.w3.org/1999/html">Language:
English
| </span>
<span class="identifiers">
<span class="id identifier oa_none" title="none">
<a style="color:blue" title="10.1155/2023/6746326" target="_blank" href="https://doi.org/10.1155/2023/6746326">
DOI
</a>
</span>
<span class="id identifier oa_none" title="none">
<a style="color:blue" title="000971801800001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/000971801800001">
WoS
</a>
</span>
<span class="id identifier oa_none" title="none">
<a style="color:blue" title="85152633565" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85152633565">
Scopus
</a>
</span>
</span>
<div class="publication-citation">
<a target="_blank" href="/api/publication?cond=citations.related;eq;33911892&sort=publishedYear,desc&sort=title">
Number of cited publications: 2
</a>
</div>
<div class="mtid"><span class="long-pub-mtid">Publication: 33911892</span>
| <span class="status-data status-VALIDATED"> Validated
</span>
Citing
| <span class="type-subtype">Journal Article
( Article
)
</span>
| <span class="pub-category">Scientific</span>
| <span class="publication-sourceOfData">WoS-XML</span>
</div>
<div class="lastModified">Last Modified: 2023.05.30. 00:37 Admin Szuper (admin)
</div>
<pre class="comment" style="margin-top: 0; margin-bottom: 0;"><u>Comments</u>: Cited By :1
Export Date: 9 October 2023
CODEN: BRJOF
Correspondence Address: Zhang, L.; Third Affiliated Hospital of Zhengzhou University, China; email: 540185181@qq.com
Chemicals/CAS: pentetic acid, 14047-41-7, 67-43-6; proton, 12408-02-5, 12586-59-3; Ki-67 Antigen
Tradenames...</pre>
</div></div>JournalArticle34216976APPROVEDtrueCited By :1
Export Date: 26 October 2023
CODEN: BRJOF
Correspondence Address: Westcott, L.Z.; Department of Surgery, United States; email: lauren.westcott@bswhealth.org0false2023-10-26T11:37:42.911+00002023-10-26T11:36:09.995+00002023-10-26T07:29:49.592+0000true10070075NádasOrsolya
/api/admin/10070075
Admintrue2023-10-26T11:36:10.411+00002023-10-26T11:36:10.411+0000falsefalsetrue2424
/api/publicationtype/24
PublicationType1true24JournalArticletrue1134514Survey papertrue2424
/api/publicationtype/24
PublicationType1true24JournalArticle
/api/subtype/1134514
Összefoglaló cikkSubType102true1134514true1
/api/category/1
Categorytrue1Westcott, L.Z.Development of the Breast Surgical Oncology Fellowship in the United Statestruetrue
/api/journal/10006504
REVIEWEDtruefalse10006504false10006504true1075-122X1524-4741JournalFOREIGN20223342910334291020222023truetruetruefalsefalseNONE2023-10-26false00000000000011Q2falsefalsefalsefalse2024-01-24T12:36:09.837+000011030trueLanguage10002
/api/language/10002
AngolEnglishtrue2truePersonAuthorship110880278
/api/authorship/110880278
10.33333334truefalsetrueWestcottL.Z.truefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship110880279
/api/authorship/110880279
20.33333334falsefalsefalseJonesR.C.truefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship110880280
/api/authorship/110880280
30.33333334falsetruefalseFleshmanJ.W.truefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePublicationIdentifier24569446
/api/publicationidentifier/24569446
10.1155/2022/3342910https://doi.org/10.1155/2022/3342910falsetruePublicationIdentifier24569447
/api/publicationidentifier/24569447
000805123200001https://www.webofscience.com/wos/woscc/full-record/000805123200001falsetruePublicationIdentifier24569445
/api/publicationidentifier/24569445
85131177183http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85131177183falsetrueSjrRating11319078
/api/sjrrating/11319078
2530.49journalRatingType10002
/api/ratingtype/10002
sjrtruetrueClassificationExternal2746
/api/classificationexternal/2746
true2746trueQ2DIRECTtruetrue
/api/publication/34216976
<div class="JournalArticle Publication short-list"> <div class="authors"> <span class="author-name" > Westcott, L.Z. ✉ </span> <span class="author-type"> </span> ; <span class="author-name" > Jones, R.C. </span> <span class="author-type"> </span> ; <span class="author-name" > Fleshman, J.W. </span> <span class="author-type"> </span> </div ><div class="title"><a href="/gui2/?mode=browse¶ms=publication;34216976" mtid="34216976" target="_blank">Development of the Breast Surgical Oncology Fellowship in the United States</a></div> <div class="pub-info"> <span class="journal-title">BREAST JOURNAL</span> <span class="journal-volume">2022</span> <span class="page"> Paper: 3342910 </span> <span class="year">(2022)</span> </div> <div class="pub-end"><div class="identifier-list"> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:black" title="10.1155/2022/3342910" target="_blank" href="https://doi.org/10.1155/2022/3342910"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:black" title="000805123200001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/000805123200001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:black" title="85131177183" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85131177183"> Scopus </a> </span> </span> </div> <div class="short-pub-prop-list"> <span class="short-pub-mtid"> Publication:34216976 </span> <span class="status-holder"><span class="status-data status-APPROVED"> Published </span></span> <span class="pub-core"> Citing </span> <span class="pub-type">Journal Article (Survey paper ) </span> <!-- && !record.category.scientific --> <span class="pub-category">Scientific</span> </div> </div> </div><div class="JournalArticle Publication long-list">
<div class="authors">
<img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png">
<div class="autype autype0"> <span class="author-name" >Westcott L.Z. ✉
</span>
;
<span class="author-name" >Jones R.C.
</span>
;
<span class="author-name" >Fleshman J.W.
</span>
</div>
</div>
<div class="title"><a href="/gui2/?mode=browse¶ms=publication;34216976" target="_blank">Development of the Breast Surgical Oncology Fellowship in the United States</a></div> <div> <span class="journal-title">BREAST JOURNAL</span>
<span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/1075-122X">1075-122X</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1524-4741">1524-4741</a>)</span>:
<span class="journal-volume">2022</span>
<span class="page">
Paper 3342910.
</span> <span class="year">(2022)</span>
</div>
<div class="pub-footer">
<span class="language" xmlns="http://www.w3.org/1999/html">Language:
English
| </span>
<span class="identifiers">
<span class="id identifier oa_none" title="none">
<a style="color:black" title="10.1155/2022/3342910" target="_blank" href="https://doi.org/10.1155/2022/3342910">
DOI
</a>
</span>
<span class="id identifier oa_none" title="none">
<a style="color:black" title="000805123200001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/000805123200001">
WoS
</a>
</span>
<span class="id identifier oa_none" title="none">
<a style="color:black" title="85131177183" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85131177183">
Scopus
</a>
</span>
</span>
<div class="publication-citation">
<a target="_blank" href="/api/publication?cond=citations.related;eq;34216976&sort=publishedYear,desc&sort=title">
Number of cited publications: 1
</a>
</div>
<div class="mtid"><span class="long-pub-mtid">Publication: 34216976</span>
| <span class="status-data status-APPROVED"> Published
</span>
Citing
| <span class="type-subtype">Journal Article
( Survey paper
)
</span>
| <span class="pub-category">Scientific</span>
| <span class="publication-sourceOfData">Scopus</span>
</div>
<div class="lastModified">Last Modified: 2023.10.26. 13:36 Orsolya Nádas (OOI admin4)
</div>
<pre class="comment" style="margin-top: 0; margin-bottom: 0;"><u>Comments</u>: Cited By :1
Export Date: 26 October 2023
CODEN: BRJOF
Correspondence Address: Westcott, L.Z.; Department of Surgery, United States; email: lauren.westcott@bswhealth.org</pre>
</div></div>JournalArticle33357670VALIDATEDtrue0false2022-12-16T19:13:31.114+00002022-12-16T19:12:18.657+00002022-12-16T19:12:16.687+0000true521SzuperAdmin
/api/admin/521
Admintrue2022-12-16T19:12:16.515+00002022-12-16T19:12:16.515+00002022-12-16T19:12:16.968+0000true521SzuperAdmin
/api/admin/521
Admintruefalsefalsetrue2424
/api/publicationtype/24
PublicationType1true24JournalArticletrue10000059Articletrue2424
/api/publicationtype/24
PublicationType1true24JournalArticle
/api/subtype/10000059
SzakcikkSubType101true10000059true1
/api/category/1
Categorytrue1Tasli, FundaThe Importance of the Pathological Perspective in the Management of the Invasive Lobular Carcinomatruetrue
/api/journal/10006504
REVIEWEDtruefalse10006504false10006504true1075-122X1524-4741JournalFOREIGN20222461242246124272022Background. Invasive lobular carcinomas (ILC) account for 10-15% of all breast cancers and are the second most common histological form of breast cancer. They usually show a discohesive pattern of single cell infiltration, tend to be multifocal, and the tumor may not be accompanied by a stromal reaction. Because of these histological features, which are not common in other breast tumors, radiological detection of the tumor may be difficult, and its pathological evaluation in terms of size and spread is often problematic. The SSO-ASTRO guideline defines the negative surgical margin in breast-conserving surgeries as the absence of tumor detection on the ink. However, surgical margin assessment in invasive lobular carcinomas has not been much discussed from the pathological perspective. Methods. The study included 79 cases diagnosed with invasive lobular carcinoma by a Tru-cut biopsy where operated in our center between 2014 and 2021. Clinicopathological characteristics of the cases, results of an intraoperative frozen evaluation in cases that underwent conservative surgery, the necessity of re-excision and complementary mastectomy, and consistency in radiological and pathological response evaluation in cases receiving neoadjuvant treatment were questioned. Results. The tumor was multifocal in 37 (46.8%) cases and single tumor focus in 42 (53.2%) cases. When the entire patient population was evaluated, regardless of focality, mastectomy was performed in 27 patients (34.2%) and breast-conserving surgery (BCS) was performed in 52 patients (65.8%). Of the 52 patients who underwent BCS, 26 (50%) required an additional surgical procedure (cavity revision or completion mastectomy). There is a statistical relationship between tumor size and additional surgical intervention (p < 0.05). BCS was performed in 7 of 12 patients who were operated on after neoadjuvant treatment, but all of them were reoperated with the same or a second session and turned to mastectomy. Neoadjuvant treatment and the need for reoperation were statistically significant (p < 0.05). Additional surgical procedures were performed in 20 (44.4%) of 45 patients in BCS cases who did not receive neoadjuvant therapy. Conclusions. Diagnostic difficulties in the intraoperative frozen evaluation of invasive lobular carcinoma are due to the different histopathological patterns of the ILC. In our study, it was determined that large tumor size and neoadjuvant therapy increased the need for additional surgical procedures. It is thought that the pathological perspective is the determining factor in order to minimize the negative effects such as unsuccessful cosmesis, an additional surgical burden on the patient, and cost increase that may occur with additional surgical procedures; for this reason, new approaches should be discussed in the treatment planning of invasive lobular carcinoma cases.2022truetruetruefalsefalseNONE2022-12-16false00000000000011Q2falsefalsefalsefalse140140trueLanguage10002
/api/language/10002
AngolEnglishtrue2truePersonAuthorship105048906
/api/authorship/105048906
10.071428575truefalsetrueTasliFundatruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105048907
/api/authorship/105048907
20.071428575falsefalsefalseCavdarDemettruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105048908
/api/authorship/105048908
30.071428575falsefalsefalseKececiSibel DemirtruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105048909
/api/authorship/105048909
40.071428575falsefalsefalseZengelBahatruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105048910
/api/authorship/105048910
50.071428575falsefalsefalseAdibelliZehra HilaltruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105048911
/api/authorship/105048911
60.071428575falsefalsefalseDalGamzetruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105048912
/api/authorship/105048912
70.071428575falsefalsefalseGonenIremtruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105048913
/api/authorship/105048913
80.071428575falsefalsefalseOzOzdentruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105048914
/api/authorship/105048914
90.071428575falsefalsefalseYilmazCengiztruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105048915
/api/authorship/105048915
100.071428575falsefalsefalseOzdemirOzlemtruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105048916
/api/authorship/105048916
110.071428575falsefalsefalseMollamehmetogluHulyatruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105048917
/api/authorship/105048917
120.071428575falsefalsefalseDilekIsmailtruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105048918
/api/authorship/105048918
130.071428575falsefalsefalseIlhanEnvertruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105048919
/api/authorship/105048919
140.071428575falsetruefalseUsluAdamtruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePublicationIdentifier22358792
/api/publicationidentifier/22358792
10.1155/2022/2461242https://doi.org/10.1155/2022/2461242falsetruePublicationIdentifier22358791
/api/publicationidentifier/22358791
IDENTICAL000869056400001https://www.webofscience.com/wos/woscc/full-record/WOS:000869056400001falsetrueClassification12215
/api/classification/12215
truetrueSjrRating11319052
/api/sjrrating/11319052
2120.49journalRatingType10002
/api/ratingtype/10002
sjrtruetrueClassificationExternal2746
/api/classificationexternal/2746
true2746trueQ2FROM_LAST_YEARtruetrue
/api/publication/33357670
<div class="JournalArticle Publication short-list"> <div class="authors"> <span class="author-name" > Tasli, Funda ✉ </span> <span class="author-type"> </span> ; <span class="author-name" > Cavdar, Demet </span> <span class="author-type"> </span> ; <span class="author-name" > Kececi, Sibel Demir </span> <span class="author-type"> </span> ; <span class="author-name" > Zengel, Baha </span> <span class="author-type"> </span> ; <span class="author-name" > Adibelli, Zehra Hilal </span> <span class="author-type"> </span> ; <span class="author-name" > Dal, Gamze </span> <span class="author-type"> </span> ; <span class="author-name" > Gonen, Irem </span> <span class="author-type"> </span> ; <span class="author-name" > Oz, Ozden </span> <span class="author-type"> </span> ; <span class="author-name" > Yilmaz, Cengiz </span> <span class="author-type"> </span> ; <span class="author-name" > Ozdemir, Ozlem </span> <span class="author-type"> </span> et al. </div ><div class="title"><a href="/gui2/?mode=browse¶ms=publication;33357670" mtid="33357670" target="_blank">The Importance of the Pathological Perspective in the Management of the Invasive Lobular Carcinoma</a></div> <div class="pub-info"> <span class="journal-title">BREAST JOURNAL</span> <span class="journal-volume">2022</span> <span class="page"> Paper: 2461242 , 7 p. </span> <span class="year">(2022)</span> </div> <div class="pub-end"><div class="identifier-list"> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:black" title="10.1155/2022/2461242" target="_blank" href="https://doi.org/10.1155/2022/2461242"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="000869056400001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/WOS:000869056400001"> WoS </a> </span> </span> </div> <div class="short-pub-prop-list"> <span class="short-pub-mtid"> Publication:33357670 </span> <span class="status-holder"><span class="status-data status-VALIDATED"> Validated </span></span> <span class="pub-core"> Citing </span> <span class="pub-type">Journal Article (Article ) </span> <!-- && !record.category.scientific --> <span class="pub-category">Scientific</span> </div> </div> </div><div class="JournalArticle Publication long-list">
<div class="authors">
<img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png">
<div class="autype autype0"> <span class="author-name" >Tasli Funda ✉
</span>
;
<span class="author-name" >Cavdar Demet
</span>
;
<span class="author-name" >Kececi Sibel Demir
</span>
;
<span class="author-name" >Zengel Baha
</span>
;
<span class="author-name" >Adibelli Zehra Hilal
</span>
;
<span class="author-name" >Dal Gamze
</span>
;
<span class="author-name" >Gonen Irem
</span>
;
<span class="author-name" >Oz Ozden
</span>
;
<span class="author-name" >Yilmaz Cengiz
</span>
;
<span class="author-name" >Ozdemir Ozlem
</span>
;
<span class="author-name" >Mollamehmetoglu Hulya
</span>
;
<span class="author-name" >Dilek Ismail
</span>
;
<span class="author-name" >Ilhan Enver
</span>
;
<span class="author-name" >Uslu Adam
</span>
</div>
</div>
<div class="title"><a href="/gui2/?mode=browse¶ms=publication;33357670" target="_blank">The Importance of the Pathological Perspective in the Management of the Invasive Lobular Carcinoma</a></div> <div> <span class="journal-title">BREAST JOURNAL</span>
<span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/1075-122X">1075-122X</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1524-4741">1524-4741</a>)</span>:
<span class="journal-volume">2022</span>
<span class="page">
Paper 2461242.
7 p.
</span> <span class="year">(2022)</span>
</div>
<div class="pub-footer">
<span class="language" xmlns="http://www.w3.org/1999/html">Language:
English
| </span>
<span class="identifiers">
<span class="id identifier oa_none" title="none">
<a style="color:black" title="10.1155/2022/2461242" target="_blank" href="https://doi.org/10.1155/2022/2461242">
DOI
</a>
</span>
<span class="id identifier oa_none" title="none">
<a style="color:blue" title="000869056400001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/WOS:000869056400001">
WoS
</a>
</span>
</span>
<div class="publication-citation">
<a target="_blank" href="/api/publication?cond=citations.related;eq;33357670&sort=publishedYear,desc&sort=title">
Number of cited publications: 1
</a>
</div>
<div class="mtid"><span class="long-pub-mtid">Publication: 33357670</span>
| <span class="status-data status-VALIDATED"> Validated
</span>
Citing
| <span class="type-subtype">Journal Article
( Article
)
</span>
| <span class="pub-category">Scientific</span>
| <span class="publication-sourceOfData">WoS-XML</span>
</div>
<div class="lastModified">Last Modified: 2022.12.16. 20:12 Admin Szuper (admin)
</div>
</div></div>JournalArticle33357089VALIDATEDtrueDepartment of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Ashton Street, Liverpool, L69 3GE, United Kingdom
The Clatterbridge Cancer Centre NHS Foundation Trust, 65 Pembroke Place, Liverpool, L7 8YA, United Kingdom
Liverpool Clinical Trials Centre, University of Liverpool, Liverpool, L69 3BX, United Kingdom
Cited By :1
Export Date: 31 May 2023
CODEN: BRJOF
Correspondence Address: Palmieri, C.; Department of Molecular and Clinical Cancer Medicine, Ashton Street, United Kingdom; email: c.palmieri@liverpool.ac.uk
Chemicals/CAS: carboplatin, 41575-94-4; cyclophosphamide, 50-18-0, 6055-19-2; docetaxel, 114977-28-5; doxorubicin, 23214-92-8, 25316-40-9; epirubicin, 56390-09-1, 56420-45-2; filgrastim, 121181-53-1; fluorouracil, 51-21-8; paclitaxel, 33069-62-4; pertuzumab, 380610-27-5; trastuzumab, 180288-69-1, 1446410-98-5; zoledronic acid, 118072-93-8, 131654-46-1, 165800-06-6, 165800-07-7; epidermal growth factor receptor 2, 137632-09-8; Antibodies, Monoclonal, Humanized; pertuzumab; Receptor, ErbB-2; Trastuzumab
Tradenames: adriamycin0false2023-05-31T07:45:08.160+00002022-12-16T18:16:51.831+00002022-12-16T18:16:49.976+0000true521SzuperAdmin
/api/admin/521
Admintrue2023-05-31T07:43:57.428+00002022-12-16T18:16:50.240+0000true521SzuperAdmin
/api/admin/521
Admintruefalsefalsetrue2424
/api/publicationtype/24
PublicationType1true24JournalArticletrue10000059Articletrue2424
/api/publicationtype/24
PublicationType1true24JournalArticle
/api/subtype/10000059
SzakcikkSubType101true10000059true1
/api/category/1
Categorytrue1Hall, Benjamin JamesNeoadjuvant Trastuzumab and Pertuzumab for Early HER2-Positive Breast Cancer: A Real World Experiencetruetrue
/api/journal/10006504
REVIEWEDtruefalse10006504false10006504true1075-122X1524-4741JournalFOREIGN202271461727146172102022Background. Randomized studies of neoadjuvant (NA) trastuzumab and pertuzumab combined with chemotherapy for HER2-positive breast cancers (BC) have reported pathological complete response (pCR) rates of 39 to 61%. This study aimed to determine the real-world efficacy and toxicity of NA trastuzumab and pertuzumab combined with chemotherapy in a UK tertiary referral cancer centre. Methods. HER2-positive early BC patients given neoadjuvant chemotherapy with trastuzumab and pertuzumab between October 2016 and February 2018 at our tertiary referral cancer centre were identified via pharmacy records. Clinico-pathological information, treatment regimens, treatment-emergent toxicities, operative details, and pathological responses and outcomes were recorded. Results. 78 female patients were identified; 2 had bilateral diseases and 48 of 78 (62%) were node positive at presentation. 55 of 80 (71%) tumours were ER-positive. PCR occurred in 37 of 78 (46.3%; 95% CI: 35.3-57.2%) patients. 14 of 23 (60.8%) patients with ER-negative tumours achieved pCR; 23 of 55 (41.8%) were ER-positive and 6 of 19 (31.6%) were ER-positive and PgR-positive. No cardiac toxicity was documented. Diarrhoea occurred in 53 of 72 (74%) patients. Grade 3-4 toxicity occurred in >= 2% patients. These were diarrhoea, fatigue, and infection. The Median follow up period was 45.2 months (95% CI 43.8-46.3) with 71 of 78 (91.0%) remaining disease-free and 72 of 78 (92.3%) alive. Estimated OS at 2 years 86% (95% CI: 75-99%). Conclusion. This data confirms the efficacy of neoadjuvant chemotherapy combined with dual HER2 directed therapy. While no cardiac toxicity was observed, diarrhoea occurred frequently. The low pCR rate observed in ER and PgR-positive BCs warrants further investigation and consideration of strategies to increase the pCR rate.2022truetruetruefalsefalseNONE2023-05-31false00000000000011Q2falsefalsefalsefalse110240trueLanguage10002
/api/language/10002
AngolEnglishtrue2truePersonAuthorship105045064
/api/authorship/105045064
10.041666668truefalsefalseHallBenjamin JamestruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105045065
/api/authorship/105045065
20.041666668falsefalsefalseBhojwaniAjay AshoktruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105045066
/api/authorship/105045066
30.041666668falsefalsefalseWongHelentruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105045067
/api/authorship/105045067
40.041666668falsefalsefalseLawAndreatruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105045068
/api/authorship/105045068
50.041666668falsefalsefalseFlintHelentruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105045069
/api/authorship/105045069
60.041666668falsefalsefalseAhmedEliyaztruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105045070
/api/authorship/105045070
70.041666668falsefalsefalseInnesHelentruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105045071
/api/authorship/105045071
80.041666668falsefalsefalseCliffJoannetruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105045072
/api/authorship/105045072
90.041666668falsefalsefalseMalikZaftruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105045073
/api/authorship/105045073
100.041666668falsefalsefalseO'HaganJulie ElizabethtruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105045074
/api/authorship/105045074
110.041666668falsefalsefalseHallAllisontruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105045075
/api/authorship/105045075
120.041666668falsefalsefalseSripadamRajaramtruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105045076
/api/authorship/105045076
130.041666668falsefalsefalseTolanShauntruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105045077
/api/authorship/105045077
140.041666668falsefalsefalseAliZulfiqartruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105045078
/api/authorship/105045078
150.041666668falsefalsefalseHartClaretruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105045079
/api/authorship/105045079
160.041666668falsefalsefalseErringtonDouglastruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105045080
/api/authorship/105045080
170.041666668falsefalsefalseAlamFaridatruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105045081
/api/authorship/105045081
180.041666668falsefalsefalseGiulianiRosatruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105045082
/api/authorship/105045082
190.041666668falsefalsefalseMehtaShavetatruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105045083
/api/authorship/105045083
200.041666668falsefalsefalseKhanduriSheenatruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105045084
/api/authorship/105045084
210.041666668falsefalsefalseThorpNickytruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105045085
/api/authorship/105045085
220.041666668falsefalsefalseJacksonRichardtruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105045086
/api/authorship/105045086
230.041666668falsefalsefalseCicconiSilviatruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship105045087
/api/authorship/105045087
240.041666668falsetruetruePalmieriCarlotruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePublicationIdentifier22357614
/api/publicationidentifier/22357614
IDENTICAL10.1155/2022/7146172https://doi.org/10.1155/2022/7146172falsetruePublicationIdentifier22357613
/api/publicationidentifier/22357613
IDENTICAL000825463600001https://www.webofscience.com/wos/woscc/full-record/000825463600001falsetruePublicationIdentifier23815475
/api/publicationidentifier/23815475
IDENTICAL85133965920http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85133965920falsetruePublicationIdentifier22408432
/api/publicationidentifier/22408432
IDENTICAL35833190http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=35833190&dopt=AbstractfalsetrueClassification12215
/api/classification/12215
truetrueSjrRating11319078
/api/sjrrating/11319078
2530.49journalRatingType10002
/api/ratingtype/10002
sjrtruetrueClassificationExternal2746
/api/classificationexternal/2746
true2746trueQ2DIRECTtruetrue
/api/publication/33357089
<div class="JournalArticle Publication short-list"> <div class="authors"> <span class="author-name" > Hall, Benjamin James </span> <span class="author-type"> </span> ; <span class="author-name" > Bhojwani, Ajay Ashok </span> <span class="author-type"> </span> ; <span class="author-name" > Wong, Helen </span> <span class="author-type"> </span> ; <span class="author-name" > Law, Andrea </span> <span class="author-type"> </span> ; <span class="author-name" > Flint, Helen </span> <span class="author-type"> </span> ; <span class="author-name" > Ahmed, Eliyaz </span> <span class="author-type"> </span> ; <span class="author-name" > Innes, Helen </span> <span class="author-type"> </span> ; <span class="author-name" > Cliff, Joanne </span> <span class="author-type"> </span> ; <span class="author-name" > Malik, Zaf </span> <span class="author-type"> </span> ; <span class="author-name" > O'Hagan, Julie Elizabeth </span> <span class="author-type"> </span> et al. </div ><div class="title"><a href="/gui2/?mode=browse¶ms=publication;33357089" mtid="33357089" target="_blank">Neoadjuvant Trastuzumab and Pertuzumab for Early HER2-Positive Breast Cancer: A Real World Experience</a></div> <div class="pub-info"> <span class="journal-title">BREAST JOURNAL</span> <span class="journal-volume">2022</span> <span class="page"> Paper: 7146172 , 10 p. </span> <span class="year">(2022)</span> </div> <div class="pub-end"><div class="identifier-list"> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.1155/2022/7146172" target="_blank" href="https://doi.org/10.1155/2022/7146172"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="000825463600001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/000825463600001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85133965920" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85133965920"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="35833190" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=35833190&dopt=Abstract"> PubMed </a> </span> </span> </div> <div class="short-pub-prop-list"> <span class="short-pub-mtid"> Publication:33357089 </span> <span class="status-holder"><span class="status-data status-VALIDATED"> Validated </span></span> <span class="pub-core"> Citing </span> <span class="pub-type">Journal Article (Article ) </span> <!-- && !record.category.scientific --> <span class="pub-category">Scientific</span> </div> </div> </div><div class="JournalArticle Publication long-list">
<div class="authors">
<img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png">
<div class="autype autype0"> <span class="author-name" >Hall Benjamin James
</span>
;
<span class="author-name" >Bhojwani Ajay Ashok
</span>
;
<span class="author-name" >Wong Helen
</span>
;
<span class="author-name" >Law Andrea
</span>
;
<span class="author-name" >Flint Helen
</span>
;
<span class="author-name" >Ahmed Eliyaz
</span>
;
<span class="author-name" >Innes Helen
</span>
;
<span class="author-name" >Cliff Joanne
</span>
;
<span class="author-name" >Malik Zaf
</span>
;
<span class="author-name" >O'Hagan Julie Elizabeth
</span>
;
<span class="author-name" >Hall Allison
</span>
;
<span class="author-name" >Sripadam Rajaram
</span>
;
<span class="author-name" >Tolan Shaun
</span>
;
<span class="author-name" >Ali Zulfiqar
</span>
;
<span class="author-name" >Hart Clare
</span>
;
<span class="author-name" >Errington Douglas
</span>
;
<span class="author-name" >Alam Farida
</span>
;
<span class="author-name" >Giuliani Rosa
</span>
;
<span class="author-name" >Mehta Shaveta
</span>
;
<span class="author-name" >Khanduri Sheena
</span>
;
<span class="author-name" >Thorp Nicky
</span>
;
<span class="author-name" >Jackson Richard
</span>
;
<span class="author-name" >Cicconi Silvia
</span>
;
<span class="author-name" >Palmieri Carlo ✉
</span>
</div>
</div>
<div class="title"><a href="/gui2/?mode=browse¶ms=publication;33357089" target="_blank">Neoadjuvant Trastuzumab and Pertuzumab for Early HER2-Positive Breast Cancer: A Real World Experience</a></div> <div> <span class="journal-title">BREAST JOURNAL</span>
<span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/1075-122X">1075-122X</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1524-4741">1524-4741</a>)</span>:
<span class="journal-volume">2022</span>
<span class="page">
Paper 7146172.
10 p.
</span> <span class="year">(2022)</span>
</div>
<div class="pub-footer">
<span class="language" xmlns="http://www.w3.org/1999/html">Language:
English
| </span>
<span class="identifiers">
<span class="id identifier oa_none" title="none">
<a style="color:blue" title="10.1155/2022/7146172" target="_blank" href="https://doi.org/10.1155/2022/7146172">
DOI
</a>
</span>
<span class="id identifier oa_none" title="none">
<a style="color:blue" title="000825463600001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/000825463600001">
WoS
</a>
</span>
<span class="id identifier oa_none" title="none">
<a style="color:blue" title="85133965920" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85133965920">
Scopus
</a>
</span>
<span class="id identifier oa_none" title="none">
<a style="color:blue" title="35833190" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=35833190&dopt=Abstract">
PubMed
</a>
</span>
</span>
<div class="publication-citation">
<a target="_blank" href="/api/publication?cond=citations.related;eq;33357089&sort=publishedYear,desc&sort=title">
Number of cited publications: 1
</a>
</div>
<div class="mtid"><span class="long-pub-mtid">Publication: 33357089</span>
| <span class="status-data status-VALIDATED"> Validated
</span>
Citing
| <span class="type-subtype">Journal Article
( Article
)
</span>
| <span class="pub-category">Scientific</span>
| <span class="publication-sourceOfData">WoS-XML</span>
</div>
<div class="lastModified">Last Modified: 2022.12.16. 19:16 Admin Szuper (admin)
</div>
<pre class="comment" style="margin-top: 0; margin-bottom: 0;"><u>Comments</u>: Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Ashton Street, Liverpool, L69 3GE, United Kingdom
The Clatterbridge Cancer Centre NHS Foundation Trust, 65 Pembroke Place, Liverpool, L7 8YA, United Kingdom
Liverpool Clinical Trials Centre, University of Liverpoo...</pre>
</div></div>JournalArticle33344522VALIDATEDtrue0false2022-12-15T21:06:54.552+00002022-12-15T21:05:35.977+00002022-12-15T21:05:34.269+0000true521SzuperAdmin
/api/admin/521
Admintrue2022-12-15T21:05:34.103+00002022-12-15T21:05:34.103+00002022-12-15T21:05:34.380+0000true521SzuperAdmin
/api/admin/521
Admintruefalsefalsetrue2424
/api/publicationtype/24
PublicationType1true24JournalArticletrue1134514Survey papertrue2424
/api/publicationtype/24
PublicationType1true24JournalArticle
/api/subtype/1134514
Összefoglaló cikkSubType102true1134514true1
/api/category/1
Categorytrue1Gatabi, Zahra RezanejadThe Accuracy of Electrical Impedance Tomography for Breast Cancer Detection: A Systematic Review and Meta-Analysistruetrue
/api/journal/10006504
REVIEWEDtruefalse10006504false10006504true1075-122X1524-4741JournalFOREIGN20228565490856549092022Introduction. Incidence of breast cancer (BC) in 2020 is about 2.26 million new cases. It is the first common cancer accounting for 11.7% of all cancer worldwide. Disease complications and the mortality rate of breast cancer are highly dependent on the early diagnosis. Therefore, novel human breast-imaging techniques play an important role in minimizing the breast cancer morbidity and mortality rate. Electrical impedance tomography (EIT) is a noninvasive technique to image the breast using the electrical impedance behavior of the body tissues. Objectives. The aims of this manuscript are as follows: (1) a comprehensive investigation of the accuracy of EIT for breast cancer diagnosis through searching pieces of evidence in the valid databases and (2) meta-analyses of the results. Methods. The systematic search was performed in the electronic databases including PubMed, Web of Science, EMBASE, Science Direct, ProQuest, Scopus, and Google Scholar without time and language limitation until January 2021. Search terms were "EIT" and "Breast Cancer" with their synonyms. Relevant studies were included based on PRISMA and study objectives. Quality of studies and risk of bias were performed by QUADAS-2 tools. Then, relevant data were extracted in Excel form. The hierarchical/bivariate meta-analysis was performed with "metandi" package for the ROC plot of sensitivity and specificity. Forest plot of the Accuracy index and double arcsine transformations was applied to stabilize the variance. The heterogeneity of the studies was evaluated by the forest plots, chi 2 test (assuming a significance at the a-level of 10%), and the I-2 statistic for the Accuracy index. Results. A total of 4027 articles were found. Finally, 12 of which met our criteria. Overall, these articles included studies of 5487 breast cancer patients. EIT had an overall pooled sensitivity and specificity of 75.88% (95% CI, 61.92% to 85.89%) and 82.04% (95% CI, 69.72% to 90.06%), respectively. The pooled diagnostic odds ratio was 14.37 (95% CI, 6.22% to 33.20%), and the pooled effect of accuracy was 0.79 with 95% CI (0.73, 0.83). Conclusions. This study showed that EIT can be used as a useful method alongside mammography. EIT sensitivity could not be compared with the sensitivity of MRI, but in terms of specificity, it can be considered as a new method that probably can get more attention. Furthermore, large-scale studies will be needed to support the evidence.2022truetruetruefalsefalseNONE2022-12-15false00000000000011Q2falsefalsefalsefalse14060trueLanguage10002
/api/language/10002
AngolEnglishtrue2truePersonAuthorship104948704
/api/authorship/104948704
10.16666667truefalsefalseGatabiZahra RezanejadtruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship104948705
/api/authorship/104948705
20.16666667falsefalsefalseMirhoseiniMehritruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship104948706
/api/authorship/104948706
30.16666667falsefalsefalseKhajealiNasrintruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship104948707
/api/authorship/104948707
40.16666667falsefalsefalseGatabiIman RezanezhadtruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship104948708
/api/authorship/104948708
50.16666667falsefalsefalseDabbaghianamiriMaedehtruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship104948709
/api/authorship/104948709
60.16666667falsetruetrueDorriSaratruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePublicationIdentifier22325084
/api/publicationidentifier/22325084
10.1155/2022/8565490https://doi.org/10.1155/2022/8565490falsetruePublicationIdentifier22325083
/api/publicationidentifier/22325083
IDENTICAL000807598500001https://www.webofscience.com/wos/woscc/full-record/WOS:000807598500001falsetruePublicationIdentifier22325085
/api/publicationidentifier/22325085
85131448614http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85131448614falsetruePublicationIdentifier22325086
/api/publicationidentifier/22325086
35711881http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=35711881&dopt=AbstractfalsetrueClassification12215
/api/classification/12215
truetrueSjrRating11319052
/api/sjrrating/11319052
2120.49journalRatingType10002
/api/ratingtype/10002
sjrtruetrueClassificationExternal2746
/api/classificationexternal/2746
true2746trueQ2FROM_LAST_YEARtruetrue
/api/publication/33344522
<div class="JournalArticle Publication short-list"> <div class="authors"> <span class="author-name" > Gatabi, Zahra Rezanejad </span> <span class="author-type"> </span> ; <span class="author-name" > Mirhoseini, Mehri </span> <span class="author-type"> </span> ; <span class="author-name" > Khajeali, Nasrin </span> <span class="author-type"> </span> ; <span class="author-name" > Gatabi, Iman Rezanezhad </span> <span class="author-type"> </span> ; <span class="author-name" > Dabbaghianamiri, Maedeh </span> <span class="author-type"> </span> ; <span class="author-name" > Dorri, Sara ✉ </span> <span class="author-type"> </span> </div ><div class="title"><a href="/gui2/?mode=browse¶ms=publication;33344522" mtid="33344522" target="_blank">The Accuracy of Electrical Impedance Tomography for Breast Cancer Detection: A Systematic Review and Meta-Analysis</a></div> <div class="pub-info"> <span class="journal-title">BREAST JOURNAL</span> <span class="journal-volume">2022</span> <span class="page"> Paper: 8565490 , 9 p. </span> <span class="year">(2022)</span> </div> <div class="pub-end"><div class="identifier-list"> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:black" title="10.1155/2022/8565490" target="_blank" href="https://doi.org/10.1155/2022/8565490"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="000807598500001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/WOS:000807598500001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:black" title="85131448614" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85131448614"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:black" title="35711881" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=35711881&dopt=Abstract"> PubMed </a> </span> </span> </div> <div class="short-pub-prop-list"> <span class="short-pub-mtid"> Publication:33344522 </span> <span class="status-holder"><span class="status-data status-VALIDATED"> Validated </span></span> <span class="pub-core"> Citing </span> <span class="pub-type">Journal Article (Survey paper ) </span> <!-- && !record.category.scientific --> <span class="pub-category">Scientific</span> </div> </div> </div><div class="JournalArticle Publication long-list">
<div class="authors">
<img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png">
<div class="autype autype0"> <span class="author-name" >Gatabi Zahra Rezanejad
</span>
;
<span class="author-name" >Mirhoseini Mehri
</span>
;
<span class="author-name" >Khajeali Nasrin
</span>
;
<span class="author-name" >Gatabi Iman Rezanezhad
</span>
;
<span class="author-name" >Dabbaghianamiri Maedeh
</span>
;
<span class="author-name" >Dorri Sara ✉
</span>
</div>
</div>
<div class="title"><a href="/gui2/?mode=browse¶ms=publication;33344522" target="_blank">The Accuracy of Electrical Impedance Tomography for Breast Cancer Detection: A Systematic Review and Meta-Analysis</a></div> <div> <span class="journal-title">BREAST JOURNAL</span>
<span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/1075-122X">1075-122X</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1524-4741">1524-4741</a>)</span>:
<span class="journal-volume">2022</span>
<span class="page">
Paper 8565490.
9 p.
</span> <span class="year">(2022)</span>
</div>
<div class="pub-footer">
<span class="language" xmlns="http://www.w3.org/1999/html">Language:
English
| </span>
<span class="identifiers">
<span class="id identifier oa_none" title="none">
<a style="color:black" title="10.1155/2022/8565490" target="_blank" href="https://doi.org/10.1155/2022/8565490">
DOI
</a>
</span>
<span class="id identifier oa_none" title="none">
<a style="color:blue" title="000807598500001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/WOS:000807598500001">
WoS
</a>
</span>
<span class="id identifier oa_none" title="none">
<a style="color:black" title="85131448614" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85131448614">
Scopus
</a>
</span>
<span class="id identifier oa_none" title="none">
<a style="color:black" title="35711881" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=35711881&dopt=Abstract">
PubMed
</a>
</span>
</span>
<div class="publication-citation">
<a target="_blank" href="/api/publication?cond=citations.related;eq;33344522&sort=publishedYear,desc&sort=title">
Number of cited publications: 1
</a>
</div>
<div class="mtid"><span class="long-pub-mtid">Publication: 33344522</span>
| <span class="status-data status-VALIDATED"> Validated
</span>
Citing
| <span class="type-subtype">Journal Article
( Survey paper
)
</span>
| <span class="pub-category">Scientific</span>
| <span class="publication-sourceOfData">WoS-XML</span>
</div>
<div class="lastModified">Last Modified: 2022.12.15. 22:05 Admin Szuper (admin)
</div>
</div></div>JournalArticle33343252VALIDATEDtrueMeirav Center for Women's Health and High-Risk Clinic, Sheba Medical Center, Ramat Gan, Israel
Division of Diagnostic Imaging, Sheba Medical Center, Ramat Gan, Affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
Department of Radiation Oncology, Sheba Medical Center, Ramat Gan, Israel
Department of Pathology, Sheba Medical Center, Ramat Gan, Israel
Export Date: 1 June 2023
CODEN: BRJOF
Correspondence Address: Faermann, R.; Meirav Center for Women's Health and High-Risk Clinic, Israel; email: rfaermann@gmail.com
Chemicals/CAS: BRCA1 Protein; BRCA1 protein, human; BRCA2 Protein; BRCA2 protein, human0false2023-06-14T12:57:09.590+00002022-12-15T18:23:34.200+00002022-12-15T18:23:32.529+0000true521SzuperAdmin
/api/admin/521
Admintrue2023-06-14T12:45:21.673+00002022-12-15T18:23:32.602+0000true521SzuperAdmin
/api/admin/521
Admintruefalsefalsetrue2424
/api/publicationtype/24
PublicationType1true24JournalArticletrue10000059Articletrue2424
/api/publicationtype/24
PublicationType1true24JournalArticle
/api/subtype/10000059
SzakcikkSubType101true10000059true1
/api/category/1
Categorytrue1Faermann, RenataDuctal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among BRCA1/BRCA2 Mutation Carrierstruetrue
/api/journal/10006504
REVIEWEDtruefalse10006504false10006504true1075-122X1524-4741JournalFOREIGN20224317693431769372022Background. While BRCA1/BRCA2 pathogenic sequence variants (PSVs) clearly confer an increased risk for invasive breast cancer, the extent to which these mutant alleles increase DCIS risk is less clear. Objective. To assess the rate of detection over a 5-year period, and MRI imaging features of pure noncalcified DCIS in a cohort of Israeli BRCA1/BRCA2 PSV carriers attending a high-risk clinic from 2015 to 2020. Materials and Methods. All female BRCA1/BRCA2 PSV-carriers followed at the Meirav High-risk clinic from 2015 to 2020 were eligible if they underwent semiannual breast imaging (MRI/mammography) and MRI-guided biopsy-proven pure DCIS. Clinical data, pathology information, and imaging characteristics were retrieved from the computerized archiving system. Results. 18/121 (15.2%) participating BRCA1 PSV carriers and 8/81 (10.1%) BRCA2 PSV-carriers who underwent MRI-guided biopsy were diagnosed with DCIS. The median age of BRCA1 carriers and BRCA2 carriers was 49.8 years and 60.6 years, respectively (p=0.55). Negative estrogen-receptor tumors were diagnosed in 13/18 (72%) BRCA1 and 2/8 (25%) BRCA2 PSV carriers (p < 0.05). Thirteen (13/18-72%) BRCA1 carriers had intermediate to high-grade or high-grade DCIS compared with 4/8 (50%) of BRCA2 carriers (p=0.03). Over the 5-year study period, 29/1100 (2.6%) BRCA1/BRCA2 PSV carriers were diagnosed with DCIS seen on MRI only. Conclusion. MRI-detected noncalcified DCIS is more frequent in BRCA1 PSV carriers compared with BRCA2 carriers, unlike the BRCA2 predominance in mammography-detected calcified DCIS. BRCA1-related DCIS is diagnosed earlier, more likely to be estrogen receptor-negative and of higher grade compared with BRCA2-related DCIS. Future prospective studies should validate these results and assess the actual impact they might have on clinical management of BRCA PSV carriers.2022truetruetruefalsefalseNONE2023-06-14false00000000000022Q2falsefalsefalsefalse260120trueLanguage10002
/api/language/10002
AngolEnglishtrue2truePersonAuthorship104937859
/api/authorship/104937859
10.083333336truefalsetrueFaermannRenatatruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship104937860
/api/authorship/104937860
20.083333336falsefalsefalseFriedmanEitantruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship104937861
/api/authorship/104937861
30.083333336falsefalsefalseKaidar-PersonOrittruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship104937862
/api/authorship/104937862
40.083333336falsefalsefalseWeidenfeldJonathantruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship104937863
/api/authorship/104937863
50.083333336falsefalsefalseBrodskyMalkatruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship104937864
/api/authorship/104937864
60.083333336falsefalsefalseShalmonAnattruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship104937865
/api/authorship/104937865
70.083333336falsefalsefalseNeimanOsnat HalshtoktruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship104937866
/api/authorship/104937866
80.083333336falsefalsefalseGotliebMichaeltruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship104937867
/api/authorship/104937867
90.083333336falsefalsefalseYagilYaeltruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship104937868
/api/authorship/104937868
100.083333336falsefalsefalseSamoochaDavidtruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship104937869
/api/authorship/104937869
110.083333336falsefalsefalseFeldmanDana MadorskytruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship104937870
/api/authorship/104937870
120.083333336falsetruefalseSklair-LevyMiritruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePublicationIdentifier22320651
/api/publicationidentifier/22320651
IDENTICAL10.1155/2022/4317693https://doi.org/10.1155/2022/4317693falsetruePublicationIdentifier22320650
/api/publicationidentifier/22320650
IDENTICAL000880607900002https://www.webofscience.com/wos/woscc/full-record/000880607900002falsetruePublicationIdentifier22320652
/api/publicationidentifier/22320652
IDENTICAL85141894015http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85141894015falsetruePublicationIdentifier22320653
/api/publicationidentifier/22320653
IDENTICAL36349178http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=36349178&dopt=AbstractfalsetrueClassification12215
/api/classification/12215
truetrueSjrRating11319078
/api/sjrrating/11319078
2530.49journalRatingType10002
/api/ratingtype/10002
sjrtruetrueClassificationExternal2746
/api/classificationexternal/2746
true2746trueQ2DIRECTtruetrue
/api/publication/33343252
<div class="JournalArticle Publication short-list"> <div class="authors"> <span class="author-name" > Faermann, Renata ✉ </span> <span class="author-type"> </span> ; <span class="author-name" > Friedman, Eitan </span> <span class="author-type"> </span> ; <span class="author-name" > Kaidar-Person, Orit </span> <span class="author-type"> </span> ; <span class="author-name" > Weidenfeld, Jonathan </span> <span class="author-type"> </span> ; <span class="author-name" > Brodsky, Malka </span> <span class="author-type"> </span> ; <span class="author-name" > Shalmon, Anat </span> <span class="author-type"> </span> ; <span class="author-name" > Neiman, Osnat Halshtok </span> <span class="author-type"> </span> ; <span class="author-name" > Gotlieb, Michael </span> <span class="author-type"> </span> ; <span class="author-name" > Yagil, Yael </span> <span class="author-type"> </span> ; <span class="author-name" > Samoocha, David </span> <span class="author-type"> </span> et al. </div ><div class="title"><a href="/gui2/?mode=browse¶ms=publication;33343252" mtid="33343252" target="_blank">Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among BRCA1/BRCA2 Mutation Carriers</a></div> <div class="pub-info"> <span class="journal-title">BREAST JOURNAL</span> <span class="journal-volume">2022</span> <span class="page"> Paper: 4317693 , 7 p. </span> <span class="year">(2022)</span> </div> <div class="pub-end"><div class="identifier-list"> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.1155/2022/4317693" target="_blank" href="https://doi.org/10.1155/2022/4317693"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="000880607900002" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/000880607900002"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85141894015" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85141894015"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="36349178" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=36349178&dopt=Abstract"> PubMed </a> </span> </span> </div> <div class="short-pub-prop-list"> <span class="short-pub-mtid"> Publication:33343252 </span> <span class="status-holder"><span class="status-data status-VALIDATED"> Validated </span></span> <span class="pub-core"> Citing </span> <span class="pub-type">Journal Article (Article ) </span> <!-- && !record.category.scientific --> <span class="pub-category">Scientific</span> </div> </div> </div><div class="JournalArticle Publication long-list">
<div class="authors">
<img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png">
<div class="autype autype0"> <span class="author-name" >Faermann Renata ✉
</span>
;
<span class="author-name" >Friedman Eitan
</span>
;
<span class="author-name" >Kaidar-Person Orit
</span>
;
<span class="author-name" >Weidenfeld Jonathan
</span>
;
<span class="author-name" >Brodsky Malka
</span>
;
<span class="author-name" >Shalmon Anat
</span>
;
<span class="author-name" >Neiman Osnat Halshtok
</span>
;
<span class="author-name" >Gotlieb Michael
</span>
;
<span class="author-name" >Yagil Yael
</span>
;
<span class="author-name" >Samoocha David
</span>
;
<span class="author-name" >Feldman Dana Madorsky
</span>
;
<span class="author-name" >Sklair-Levy Miri
</span>
</div>
</div>
<div class="title"><a href="/gui2/?mode=browse¶ms=publication;33343252" target="_blank">Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among BRCA1/BRCA2 Mutation Carriers</a></div> <div> <span class="journal-title">BREAST JOURNAL</span>
<span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/1075-122X">1075-122X</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1524-4741">1524-4741</a>)</span>:
<span class="journal-volume">2022</span>
<span class="page">
Paper 4317693.
7 p.
</span> <span class="year">(2022)</span>
</div>
<div class="pub-footer">
<span class="language" xmlns="http://www.w3.org/1999/html">Language:
English
| </span>
<span class="identifiers">
<span class="id identifier oa_none" title="none">
<a style="color:blue" title="10.1155/2022/4317693" target="_blank" href="https://doi.org/10.1155/2022/4317693">
DOI
</a>
</span>
<span class="id identifier oa_none" title="none">
<a style="color:blue" title="000880607900002" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/000880607900002">
WoS
</a>
</span>
<span class="id identifier oa_none" title="none">
<a style="color:blue" title="85141894015" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85141894015">
Scopus
</a>
</span>
<span class="id identifier oa_none" title="none">
<a style="color:blue" title="36349178" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=36349178&dopt=Abstract">
PubMed
</a>
</span>
</span>
<div class="publication-citation">
<a target="_blank" href="/api/publication?cond=citations.related;eq;33343252&sort=publishedYear,desc&sort=title">
Number of cited publications: 2
</a>
</div>
<div class="mtid"><span class="long-pub-mtid">Publication: 33343252</span>
| <span class="status-data status-VALIDATED"> Validated
</span>
Citing
| <span class="type-subtype">Journal Article
( Article
)
</span>
| <span class="pub-category">Scientific</span>
| <span class="publication-sourceOfData">WoS-XML</span>
</div>
<div class="lastModified">Last Modified: 2022.12.15. 19:23 Admin Szuper (admin)
</div>
<pre class="comment" style="margin-top: 0; margin-bottom: 0;"><u>Comments</u>: Meirav Center for Women's Health and High-Risk Clinic, Sheba Medical Center, Ramat Gan, Israel
Division of Diagnostic Imaging, Sheba Medical Center, Ramat Gan, Affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
Department of...</pre>
</div></div>JournalArticle33341063APPROVEDtrueBreast Cancer Unit, Department of Obstetrics and Gynaecology, University Hospital, 12 de Octubre, Madrid, Spain
Research Institute (imas12), Complutense University of Madrid, Madrid, Spain
Gynaecology Oncology Unit, Department of Obstetrics and Gynaecology, University Hospital 12 de Octubre, Madrid, Spain
Breast and Gynaecology Cancer Unit, Department of Medical Oncology, University Hospital, 12 de Octubre, Madrid, Spain
Department of Nuclear Medicine, University Hospital, 12 de Octubre, Madrid, Spain
Department of Pathology, University Hospital, 12 de Octubre, Madrid, Spain
Fetal Medicine Unit- Maternal and Child Health and Development Network (Red SAMIDRD 12/0026/0016), Department of Obstetrics and Gynaecology, University Hospital, 12 de Octubre, Madrid, Spain
Cited By :1
Export Date: 6 June 2023
CODEN: BRJOF
Correspondence Address: Oliver-Perez, M.R.; Research Institute (imas12), Spain; email: m.delosreyes.oliver@salud.madrid.org
Chemicals/CAS: carboplatin, 41575-94-4; cyclophosphamide, 50-18-0, 6055-19-2; paclitaxel, 33069-62-4; pertuzumab, 380610-27-5; trastuzumab, 180288-69-1, 1446410-98-50false2023-06-06T13:21:33.775+00002022-12-15T14:07:13.239+00002022-12-15T14:04:54.345+0000true10070075NádasOrsolya
/api/admin/10070075
Admintrue2023-11-09T12:56:58.089+0000falsefalsetrue2424
/api/publicationtype/24
PublicationType1true24JournalArticletrue10000059Articletrue2424
/api/publicationtype/24
PublicationType1true24JournalArticle
/api/subtype/10000059
SzakcikkSubType101true10000059true1
/api/category/1
Categorytrue1Aragon-Sanchez, SofiaAccuracy and Limitations of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients with Positive Nodestruetrue
/api/journal/10006504
REVIEWEDtruefalse10006504false10006504true1075-122X1524-4741JournalFOREIGN20221507881150788182022Background. Axillary surgical management in patients with node-positive breast cancer at the time of diagnosis converted to negative nodes through neoadjuvant chemotherapy (NAC) remains unclear. Removal of more than two sentinel nodes (SLNs) in these patients may decrease the false negative rate (FNR) of sentinel lymph node biopsies (SLNBs). We aim to analyse the detection rate (DR) and the FNR of SLNB assessment according to the number of SLNs removed. Methods. A retrospective study was performed from October 2012 to December 2018. Patients with invasive breast cancer who had a clinically node-positive disease at diagnosis and with a complete axillary response after neoadjuvant chemotherapy were selected. Patients included underwent SLNB and axillary lymph node dissection (ALND) after NAC. The SLN was considered positive if any residual disease was detected. Descriptive statistics were used to describe the clinicopathologic features and the results of SLNB and ALND. The DR of SLNB was defined as the number of patients with successful identification of SLN. Presence of residual disease in ALND and negative SLN was considered false negative. Results. A total of 368 patients with invasive breast cancer who underwent surgery after complete NAC were studied. Of them, 85 patients met the eligibility criteria and were enrolled in the study. The mean age at diagnosis was 50.8 years. Systematic lymphadenectomy was performed in all patients, with an average of 10 lymph nodes removed. The DR of SLNB was 92.9%, and the FNR was 19.1. The median number of SLNs removed was 3, and at least, three SLNs were obtained in 42 patients (53.2%). When at least three sentinel nodes were removed, the FNR decreased to 8.7%. Conclusions. In this cohort, the SLN assessment was associated with an adequate DR and a high FNR. Removing three or more SLNs decreased the FNR from 19.1% to 8.7%. Complementary approaches may be considered for axillary lymph node staging after neoadjuvant chemotherapy. The study was approved by our institution's ethics committee (Instituto de Investigacion Sanitaria Hospital 12 de Octubre (imas12), Universidad Complutense de Madrid, Madrid, Spain) ().2022truetruetruefalsefalseNONE2023-06-06false00000000000022Q2falsefalsefalsefalse2023-03-15T14:07:13.110+0000250100trueLanguage10002
/api/language/10002
AngolEnglishtrue2truePersonAuthorship104924431
/api/authorship/104924431
10.1truefalsefalseAragon-SanchezSofiatruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship104924432
/api/authorship/104924432
20.1falsefalsefalseReyesOliver-Perez M.truefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship104924433
/api/authorship/104924433
30.1falsefalsefalseMadariagaAinhoatruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship104924434
/api/authorship/104924434
40.1falsefalsefalseJoseTabuenca M.truefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship104924435
/api/authorship/104924435
50.1falsefalsefalseMartinezMariotruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship104924436
/api/authorship/104924436
60.1falsefalsefalseGalindoAlbertotruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship104924437
/api/authorship/104924437
70.1falsefalsefalseLuisaArroyo M.truefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship104924438
/api/authorship/104924438
80.1falsefalsefalseGallegoMartatruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship104924439
/api/authorship/104924439
90.1falsefalsefalseBlancoMartatruefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePersonAuthorship104924440
/api/authorship/104924440
100.1falsetruefalseCiruelos-GilEva M.truefalsefalseAuthorshipType1
/api/authorshiptype/1
0true0truefalsetruePublicationIdentifier22312970
/api/publicationidentifier/22312970
IDENTICAL10.1155/2022/1507881https://doi.org/10.1155/2022/1507881falsetruePublicationIdentifier22312971
/api/publicationidentifier/22312971
IDENTICAL000841652400001https://www.webofscience.com/wos/woscc/full-record/000841652400001falsetruePublicationIdentifier22313054
/api/publicationidentifier/22313054
IDENTICAL85136204180http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85136204180falsetruePublicationIdentifier22312972
/api/publicationidentifier/22312972
IDENTICAL36051467http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=36051467&dopt=AbstractfalsetrueKeyword6782
/api/keyword/6782
true6782trueKeyword12710
/api/keyword/12710
true12710trueKeyword17193
/api/keyword/17193
true17193trueKeyword1925691
/api/keyword/1925691
truetrueKeyword1973621
/api/keyword/1973621
truetrueKeyword1973622
/api/keyword/1973622
truetrueKeyword2629048
/api/keyword/2629048
truetrueKeyword2823922
/api/keyword/2823922
truetrueSjrRating11319078
/api/sjrrating/11319078
2530.49journalRatingType10002
/api/ratingtype/10002
sjrtruetrueClassificationExternal2746
/api/classificationexternal/2746
true2746trueQ2DIRECTtruetrue
/api/publication/33341063
<div class="JournalArticle Publication short-list"> <div class="authors"> <span class="author-name" > Aragon-Sanchez, Sofia </span> <span class="author-type"> </span> ; <span class="author-name" > Reyes, Oliver-Perez M. </span> <span class="author-type"> </span> ; <span class="author-name" > Madariaga, Ainhoa </span> <span class="author-type"> </span> ; <span class="author-name" > Jose, Tabuenca M. </span> <span class="author-type"> </span> ; <span class="author-name" > Martinez, Mario </span> <span class="author-type"> </span> ; <span class="author-name" > Galindo, Alberto </span> <span class="author-type"> </span> ; <span class="author-name" > Luisa, Arroyo M. </span> <span class="author-type"> </span> ; <span class="author-name" > Gallego, Marta </span> <span class="author-type"> </span> ; <span class="author-name" > Blanco, Marta </span> <span class="author-type"> </span> ; <span class="author-name" > Ciruelos-Gil, Eva M. </span> <span class="author-type"> </span> </div ><div class="title"><a href="/gui2/?mode=browse¶ms=publication;33341063" mtid="33341063" target="_blank">Accuracy and Limitations of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients with Positive Nodes</a></div> <div class="pub-info"> <span class="journal-title">BREAST JOURNAL</span> <span class="journal-volume">2022</span> <span class="page"> Paper: 1507881 , 8 p. </span> <span class="year">(2022)</span> </div> <div class="pub-end"><div class="identifier-list"> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.1155/2022/1507881" target="_blank" href="https://doi.org/10.1155/2022/1507881"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="000841652400001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/000841652400001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85136204180" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85136204180"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="36051467" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=36051467&dopt=Abstract"> PubMed </a> </span> </span> </div> <div class="short-pub-prop-list"> <span class="short-pub-mtid"> Publication:33341063 </span> <span class="status-holder"><span class="status-data status-APPROVED"> Published </span></span> <span class="pub-core"> Citing </span> <span class="pub-type">Journal Article (Article ) </span> <!-- && !record.category.scientific --> <span class="pub-category">Scientific</span> </div> </div> </div><div class="JournalArticle Publication long-list">
<div class="authors">
<img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png">
<div class="autype autype0"> <span class="author-name" >Aragon-Sanchez Sofia
</span>
;
<span class="author-name" >Reyes Oliver-Perez M.
</span>
;
<span class="author-name" >Madariaga Ainhoa
</span>
;
<span class="author-name" >Jose Tabuenca M.
</span>
;
<span class="author-name" >Martinez Mario
</span>
;
<span class="author-name" >Galindo Alberto
</span>
;
<span class="author-name" >Luisa Arroyo M.
</span>
;
<span class="author-name" >Gallego Marta
</span>
;
<span class="author-name" >Blanco Marta
</span>
;
<span class="author-name" >Ciruelos-Gil Eva M.
</span>
</div>
</div>
<div class="title"><a href="/gui2/?mode=browse¶ms=publication;33341063" target="_blank">Accuracy and Limitations of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients with Positive Nodes</a></div> <div> <span class="journal-title">BREAST JOURNAL</span>
<span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/1075-122X">1075-122X</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1524-4741">1524-4741</a>)</span>:
<span class="journal-volume">2022</span>
<span class="page">
Paper 1507881.
8 p.
</span> <span class="year">(2022)</span>
</div>
<div class="pub-footer">
<span class="language" xmlns="http://www.w3.org/1999/html">Language:
English
| </span>
<span class="identifiers">
<span class="id identifier oa_none" title="none">
<a style="color:blue" title="10.1155/2022/1507881" target="_blank" href="https://doi.org/10.1155/2022/1507881">
DOI
</a>
</span>
<span class="id identifier oa_none" title="none">
<a style="color:blue" title="000841652400001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/000841652400001">
WoS
</a>
</span>
<span class="id identifier oa_none" title="none">
<a style="color:blue" title="85136204180" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85136204180">
Scopus
</a>
</span>
<span class="id identifier oa_none" title="none">
<a style="color:blue" title="36051467" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=36051467&dopt=Abstract">
PubMed
</a>
</span>
</span>
<div class="publication-citation">
<a target="_blank" href="/api/publication?cond=citations.related;eq;33341063&sort=publishedYear,desc&sort=title">
Number of cited publications: 2
</a>
</div>
<div class="mtid"><span class="long-pub-mtid">Publication: 33341063</span>
| <span class="status-data status-APPROVED"> Published
</span>
Citing
| <span class="type-subtype">Journal Article
( Article
)
</span>
| <span class="pub-category">Scientific</span>
| <span class="publication-sourceOfData">WOS TAGGED</span>
</div>
<div class="lastModified">Last Modified: 2022.12.15. 15:07 Orsolya Nádas (OOI admin4)
</div>
<pre class="comment" style="margin-top: 0; margin-bottom: 0;"><u>Comments</u>: Breast Cancer Unit, Department of Obstetrics and Gynaecology, University Hospital, 12 de Octubre, Madrid, Spain
Research Institute (imas12), Complutense University of Madrid, Madrid, Spain
Gynaecology Oncology Unit, Department of Obstetrics and Gynaecology, University Hospital 12 de Octubre, Madrid, Spain
Breast and Gynaeco...</pre>
</div></div>